S&P 500   4,081.77 (+0.04%)
DOW   34,418.64 (-0.49%)
QQQ   293.95 (+0.20%)
AAPL   148.71 (+0.46%)
MSFT   255.52 (+0.15%)
META   120.69 (+2.19%)
GOOGL   101.16 (+0.17%)
AMZN   95.40 (-1.18%)
TSLA   194.19 (-0.26%)
NVDA   171.87 (+1.56%)
NIO   12.10 (-5.32%)
BABA   86.33 (-1.40%)
AMD   77.37 (-0.33%)
T   19.16 (-0.62%)
MU   55.56 (-3.63%)
CGC   3.87 (+6.91%)
F   14.06 (+1.15%)
GE   85.38 (-0.69%)
DIS   98.47 (+0.61%)
AMC   8.56 (+18.40%)
PYPL   78.35 (-0.08%)
PFE   50.96 (+1.66%)
NFLX   317.93 (+4.06%)
S&P 500   4,081.77 (+0.04%)
DOW   34,418.64 (-0.49%)
QQQ   293.95 (+0.20%)
AAPL   148.71 (+0.46%)
MSFT   255.52 (+0.15%)
META   120.69 (+2.19%)
GOOGL   101.16 (+0.17%)
AMZN   95.40 (-1.18%)
TSLA   194.19 (-0.26%)
NVDA   171.87 (+1.56%)
NIO   12.10 (-5.32%)
BABA   86.33 (-1.40%)
AMD   77.37 (-0.33%)
T   19.16 (-0.62%)
MU   55.56 (-3.63%)
CGC   3.87 (+6.91%)
F   14.06 (+1.15%)
GE   85.38 (-0.69%)
DIS   98.47 (+0.61%)
AMC   8.56 (+18.40%)
PYPL   78.35 (-0.08%)
PFE   50.96 (+1.66%)
NFLX   317.93 (+4.06%)
S&P 500   4,081.77 (+0.04%)
DOW   34,418.64 (-0.49%)
QQQ   293.95 (+0.20%)
AAPL   148.71 (+0.46%)
MSFT   255.52 (+0.15%)
META   120.69 (+2.19%)
GOOGL   101.16 (+0.17%)
AMZN   95.40 (-1.18%)
TSLA   194.19 (-0.26%)
NVDA   171.87 (+1.56%)
NIO   12.10 (-5.32%)
BABA   86.33 (-1.40%)
AMD   77.37 (-0.33%)
T   19.16 (-0.62%)
MU   55.56 (-3.63%)
CGC   3.87 (+6.91%)
F   14.06 (+1.15%)
GE   85.38 (-0.69%)
DIS   98.47 (+0.61%)
AMC   8.56 (+18.40%)
PYPL   78.35 (-0.08%)
PFE   50.96 (+1.66%)
NFLX   317.93 (+4.06%)
S&P 500   4,081.77 (+0.04%)
DOW   34,418.64 (-0.49%)
QQQ   293.95 (+0.20%)
AAPL   148.71 (+0.46%)
MSFT   255.52 (+0.15%)
META   120.69 (+2.19%)
GOOGL   101.16 (+0.17%)
AMZN   95.40 (-1.18%)
TSLA   194.19 (-0.26%)
NVDA   171.87 (+1.56%)
NIO   12.10 (-5.32%)
BABA   86.33 (-1.40%)
AMD   77.37 (-0.33%)
T   19.16 (-0.62%)
MU   55.56 (-3.63%)
CGC   3.87 (+6.91%)
F   14.06 (+1.15%)
GE   85.38 (-0.69%)
DIS   98.47 (+0.61%)
AMC   8.56 (+18.40%)
PYPL   78.35 (-0.08%)
PFE   50.96 (+1.66%)
NFLX   317.93 (+4.06%)
OTCMKTS:LZAGY

Lonza Group - LZAGY Stock Forecast, Price & News

$52.32
+1.18 (+2.31%)
(As of 11/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$51.18
$52.48
50-Day Range
$44.17
$55.73
52-Week Range
$43.85
$84.16
Volume
126,953 shs
Average Volume
129,808 shs
Market Capitalization
$38.96 billion
P/E Ratio
N/A
Dividend Yield
0.17%
Price Target
N/A

Lonza Group MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
18.83%
From $1.54 to $1.83 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.06 out of 5 stars

LZAGY stock logo

About Lonza Group (OTCMKTS:LZAGY) Stock

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia and New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. It supports customers across various aspects of design, development, and manufacturing. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. In addition, this segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. The company was founded in 1897 and is headquartered in Basel, Switzerland.

Receive LZAGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lonza Group and its competitors with MarketBeat's FREE daily newsletter.

LZAGY Stock News Headlines

LZAGY Lonza Group AG
Lonza and Touchlight collaborate on end-to-end mRNA offering
Lonza's first-half core EBITDA gains 16.5%
UPDATE 1-Lonza's first-half core EBITDA gains 16.5%
Lonza Group AG GAAP EPS of CHF39.52, revenue of CHF5.4B
Lonza's full-year core EBITDA up 20.7% on vaccine demand
Lonza Group AG ADR (LZAGY)
Should You Have Lonza Stock on Your Watchlist?
See More Headlines
Receive LZAGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lonza Group and its competitors with MarketBeat's FREE daily newsletter.

LZAGY Company Calendar

Today
12/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Tobacco products
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:LZAGY
Employees
16,540
Year Founded
1897

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.92 billion
Cash Flow
$1.83 per share
Book Value
$14.43 per share

Miscellaneous

Free Float
744,167,000
Market Cap
$38.96 billion
Optionable
Not Optionable
Beta
0.97

Social Links


Key Executives

  • Dr. Pierre-Alain Ruffieux Ph.D. (Age 53)
    Chief Exec. Officer
    Comp: $2.65M
  • Mr. Philippe Deecke (Age 50)
    Chief Financial Officer
  • Ms. Maria Soler Nunez
    Head of Group Operations
  • Mr. Dirk Oehlers
    VP of Investor Relations
  • Mr. Andreas Bohrer
    Group Gen. Counsel & Company Sec.
  • Ms. Victoria Morgan
    Head of External Communications
  • Ms. Jennifer Clancy
    Sr. Director of Global Marketing
  • Dr. Caroline Barth M.D. (Age 50)
    Chief HR Officer
  • Ms. Constance Ward
    Head of External Communications
  • Dr. Sanna Fowler
    Head of External Communications













LZAGY Stock - Frequently Asked Questions

Should I buy or sell Lonza Group stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LZAGY shares.
View LZAGY analyst ratings
or view top-rated stocks.

How have LZAGY shares performed in 2022?

Lonza Group's stock was trading at $83.50 at the beginning of 2022. Since then, LZAGY shares have decreased by 37.3% and is now trading at $52.32.
View the best growth stocks for 2022 here
.

Are investors shorting Lonza Group?

Lonza Group saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 3,200 shares, a drop of 69.8% from the October 31st total of 10,600 shares. Based on an average daily volume of 247,100 shares, the days-to-cover ratio is currently 0.0 days.
View Lonza Group's Short Interest
.

How often does Lonza Group pay dividends? What is the dividend yield for Lonza Group?

Lonza Group declared a dividend on Wednesday, May 4th. Stockholders of record on Tuesday, May 10th will be paid a dividend of $0.0895 per share on Thursday, May 26th. This represents a yield of 0.39%. The ex-dividend date is Monday, May 9th.
Read our dividend analysis for LZAGY
.

Is Lonza Group a good dividend stock?

Lonza Group (OTCMKTS:LZAGY) pays an annual dividend of $0.09 per share and currently has a dividend yield of 0.17%.
Read our dividend analysis for LZAGY.

What is Lonza Group's stock symbol?

Lonza Group trades on the OTCMKTS under the ticker symbol "LZAGY."

How do I buy shares of Lonza Group?

Shares of LZAGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lonza Group's stock price today?

One share of LZAGY stock can currently be purchased for approximately $52.32.

How much money does Lonza Group make?

Lonza Group (OTCMKTS:LZAGY) has a market capitalization of $38.96 billion and generates $5.92 billion in revenue each year.

How many employees does Lonza Group have?

The company employs 16,540 workers across the globe.

Does Lonza Group have any subsidiaries?
The following companies are subsidiares of Lonza Group: Arch Acquisition LLC, Arch Chemicals Canada Inc., Arch Chemicals Inc., Arch Chemicals Limited, Arch Chemicals Receivables LLC, Arch Chemicals SAS, Arch Personal Care Products L.P., Arch Protection Chemicals Private Limited, Arch Quimica Argentina S.R.L., Arch Quimica Brasil Ltda., Arch Timber Protection B.V., Arch Treatment Technologies Inc., Arch UK Biocides Limited, Arch Water Products France S.A.S., Arch Water Products South Africa (Pty) Ltd, Arch Wood Protection (Aust) Pty Ltd, Arch Wood Protection (M) Sdn. Bhd., Arch Wood Protection (NZ) Limited, Arch Wood Protection (SA) Pty Ltd, Arch Wood Protection Canada Corp., Arch Wood Protection Inc, Bend Research Inc., BioAtrium AG, CH Capsules Malaysia SDN BHD, Capsugel, Capsugel (Thailand) Co. Ltd, Capsugel Australia Pty Ltd, Capsugel Belgium NV, Capsugel Brasil Importação e Distribuição de Insumos Farmacêuticos e Alimentos Ltda., Capsugel Canada Corp., Capsugel Distribucion S. de R.L. de C.V., Capsugel FinanceCo II S.à r.l., Capsugel FinanceCo S.C.A., Capsugel FinanceCo S.à r.l, Capsugel France Holdings SAS, Capsugel France SAS, Capsugel Funding LLC, Capsugel Germany GmbH, Capsugel Healthcare Private Limited, Capsugel Holdings (Hong Kong) Limited, Capsugel Holdings S.à r.l., Capsugel Holdings US Inc., Capsugel Hungary Kft, Capsugel Inc., Capsugel Italy S.R.L., Capsugel Japan Inc., Capsugel Manufacturing Inc., Capsugel Middle East Sàrl, Capsugel New Zealand Limited, Capsugel Pharmaceutical and Health Products Marketing Ltd, Capsugel Philippines Inc., Capsugel Ploermel SAS, Capsugel S.à r.l., Capsugel Spain S.L., Capsugel US LLC, Capsugel de México S. de R.L. de C.V., Diacon Technologies, Diacon Technologies Limited, Hickson Ltd, InterHealth Nutraceuticals, InterHealth Nutraceuticals Incorporated, LLC Capsugel, Lonza (China) Investments Co. Ltd., Lonza AG, Lonza America Inc., Lonza Argentina S.A, Lonza Biologics Inc., Lonza Biologics Porriño S.L., Lonza Biologics Tuas Pte. Ltd, Lonza Biologics plc, Lonza Bioscience SARL, Lonza Bioscience Singapore Pte Ltd, Lonza Biotec s.r.o., Lonza Cologne GmbH, Lonza Colombia S.A.S, Lonza Copenhagen ApS, Lonza Costa Rica S.A., Lonza Geleen B.V., Lonza Guangzhou Ltd, Lonza Guangzhou Nansha Ltd, Lonza Houston Inc., Lonza Inc., Lonza India Private Limited, Lonza Israel Ltd, Lonza Japan Ltd, Lonza Luxembourg S.à r.l., Lonza Microbial Control Asia Pacific Pte Ltd, Lonza Milano S.r.l., Lonza NZ Limited, Lonza Nanjing Ltd, Lonza Netherlands B.V, Lonza Rockland Inc., Lonza Sales AG, Lonza Shanghai International Trading Ltd, Lonza Suzhou Ltd, Lonza Swiss Finanz AG, Lonza Swiss Licences AG, Lonza Verviers SPRL, Lonza Walkersville Inc., Lonza do Brasil Especialidades Quimicas Ltda., MW Encap (Holdings) Limited, MW Encap Limited, Micro-Macinazione, Micro-Macinazione SA, Octane Biotech, Octane Biotech Inc, P.T. Capsugel Indonesia, PharmaCell, Powdersize LLC, Suzhou Capsugel Limited (JV), Triangle Research Labs, Xcelience Clinical Services Ltd, Xcelience LLC, and Zelam Holdings.
Read More
How can I contact Lonza Group?

Lonza Group's mailing address is Muenchensteinerstrasse 38, Basel V8, 4002. The official website for the company is www.lonza.com. The company can be reached via phone at (161) 316-8111, via email at investor.relations@lonza.com, or via fax at 41-61-316-9111.

This page (OTCMKTS:LZAGY) was last updated on 12/1/2022 by MarketBeat.com Staff